These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23474049)

  • 1. L28. Relevance of detection techniques for ANCA testing.
    Elena C
    Presse Med; 2013 Apr; 42(4 Pt 2):582-4. PubMed ID: 23474049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA testing: the current stage and perspectives.
    Csernok E
    Clin Exp Nephrol; 2013 Oct; 17(5):615-618. PubMed ID: 23180043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
    Savige J; Trevisin M; Pollock W
    J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of different commercial ELISA systems for the detection of anti-neutrophil cytoplasm antibodies in ANCA-associated vasculitides.
    Holle JU; Herrmann K; Gross WL; Csernok E
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S66-9. PubMed ID: 22512915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
    Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
    Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.
    de Joode AA; Roozendaal C; van der Leij MJ; Bungener LB; Sanders JS; Stegeman CA
    Eur J Intern Med; 2014 Feb; 25(2):182-6. PubMed ID: 24361117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
    Avery TY; Bons J; van Paassen P; Damoiseaux J
    Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
    Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
    Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a novel chemiluminescence enzyme immunoassay (CLEIA) with enzyme-linked immunosorbent assay (ELISA) for the determination of MPO-ANCA in patients with ANCA-associated vasculitis.
    Hirose O; Itabashi M; Takei T; Nitta K
    Mod Rheumatol; 2015 Mar; 25(2):230-4. PubMed ID: 25388618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.
    Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM
    Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.
    Yamanishi Y; Ito-Ihara T; Nagao T; Uno K; Kobayashi S; Muso E; Shane PY; Firestein GS; Hashimoto H; Okazaki T; Suzuki K
    Mod Rheumatol; 2013 Sep; 23(5):963-71. PubMed ID: 23085883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
    Wallace ZS; Stone JH
    Front Immunol; 2019; 10():2855. PubMed ID: 31867013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.
    Kain R
    Presse Med; 2013 Apr; 42(4 Pt 2):584-8. PubMed ID: 23453500
    [No Abstract]   [Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?
    Cohen Tervaert JW; Damoiseaux J
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):211-9. PubMed ID: 22669754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis.
    Radice A; Bianchi L; Sinico RA
    Autoimmun Rev; 2013 Feb; 12(4):487-95. PubMed ID: 22921790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
    Deshayes S; Martin Silva N; Grandhomme F; Khoy K; Mariotte D; Boutemy J; Maigné G; Brière-Bellier C; Delmas C; Bienvenu B; Lobbedez T; de Boysson H; Aouba A
    J Rheumatol; 2019 Nov; 46(11):1502-1508. PubMed ID: 30824651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic approach to ANCA-associated vasculitides.
    Gaffo AL
    Rheum Dis Clin North Am; 2010 Aug; 36(3):491-506. PubMed ID: 20688246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paradigm shift in ANCA diagnostics : New international consensus recommendations].
    Csernok E; Kempiners N; Hellmich B
    Z Rheumatol; 2017 Mar; 76(2):143-148. PubMed ID: 28058500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasm antibodies (ANCA): Recent methodological advances-Lead to new consensus recommendations for ANCA detection.
    Csernok E; Mahrhold J; Hellmich B
    J Immunol Methods; 2018 May; 456():1-6. PubMed ID: 29395165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.